tiprankstipranks
Trending News
More News >
Medicamen Biotech Limited (IN:MEDICAMEQ)
:MEDICAMEQ
India Market

Medicamen Biotech Limited (MEDICAMEQ) Financial Statements

Compare
0 Followers

Medicamen Biotech Limited Financial Overview

Medicamen Biotech Limited's market cap is currently ₹5.66B. The company's EPS TTM is ₹6.642; its P/E ratio is 68.62; and it has a dividend yield of 0.22%. Medicamen Biotech Limited is scheduled to report earnings on February 7, 2025, and the estimated EPS forecast is ₹―. See an overview of income statement, balance sheet, and cash flow financials.
Mar 24Mar 23Mar 22Mar 21Mar 20
Income Statement
Total Revenue₹ 1.79B₹ 1.41B₹ 1.15B₹ 1.13B₹ 1.26B
Gross Profit₹ 852.01M₹ 687.74M₹ 479.88M₹ 335.16M₹ 350.35M
Operating Income₹ 516.84M₹ 176.32M₹ 178.96M₹ 168.25M₹ 168.21M
EBITDA₹ 245.66M₹ 277.12M₹ 258.07M₹ 204.25M₹ 214.11M
Net Income₹ 109.31M₹ 148.44M₹ 148.98M₹ 121.29M₹ 132.91M
Balance Sheet
Cash & Short-Term Investments₹ 147.86M₹ 207.79M₹ 38.25M₹ 16.57M₹ 17.10M
Total Assets₹ 2.95B₹ 2.79B₹ 2.26B₹ 1.94B₹ 1.81B
Total Debt₹ 311.12M₹ 241.83M₹ 257.96M₹ 188.19M₹ 114.71M
Net Debt₹ 163.26M₹ 34.04M₹ 219.71M₹ 171.63M₹ 97.62M
Total Liabilities₹ 875.67M₹ 851.03M₹ 792.24M₹ 611.18M₹ 600.66M
Stockholders' Equity₹ 2.07B₹ 1.93B₹ 1.46B₹ 1.33B₹ 1.21B
Cash Flow
Free Cash Flow₹ -130.31M₹ -128.94M₹ -44.99M₹ -51.94M₹ -248.09M
Operating Cash Flow₹ -67.44M₹ -62.93M₹ 41.09M₹ 127.72M₹ 128.02M
Investing Cash Flow₹ -55.63M₹ -58.80M₹ -84.73M₹ -178.13M₹ -372.91M
Financing Cash Flow₹ 63.13M₹ 291.27M₹ 42.98M₹ 58.39M₹ 190.63M
Currency in INR

Medicamen Biotech Limited Earnings and Revenue History

Medicamen Biotech Limited Debt to Assets

Medicamen Biotech Limited Cash Flow

Medicamen Biotech Limited Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis